{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:45:49Z","timestamp":1793339149882,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital Medical Development Research Commission","award":["2011-2018-09"],"award-info":[{"award-number":["2011-2018-09"]}]},{"name":"Beijing Hospitals Authority Talent Training Plan","award":["QMS20191706"],"award-info":[{"award-number":["QMS20191706"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited data exists regarding the pregnancy and infant outcomes of Acute Fatty Liver of Pregnancy (AFLP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospectively collected mothers with AFLP and mothers without AFLP in our center from 1\/2008 to 6\/2018. The primary assessment was to analyze and compare the frequency of negative maternal and fetal outcomes. The secondary assessment was to investigate the role of intrauterine balloon tamponade in reducing negative maternal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to 220 matched mothers, 55 AFLP mothers were younger (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.001), with fewer pregnancies (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.033), complicated with more pregnancy induced hypertension (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&lt;\u20090.001), twins(\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.002), fetal growth restriction (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.044) and male fetus (P\u2009&lt;\u20090.001). 3 (5.5%) of AFLP patients were diagnosed in the postpartum period. Mean gestational week of AFLP diagnosis was 35.25\u2009\u00b1\u20095.80\u2009weeks. Jaundice (89.1%), nausea or vomiting (58.2%), anorexia (49.1%), fatigue (45.5%) and polydipsia (30.9%) were the main prodromal symptoms. The median duration from diagnosis to delivery was 1.55\u2009\u00b1\u20094.62\u2009days and 75% (39\/52) pregnancy were terminated the pregnancy at the day of diagnosis. 78.8% (41\/52) patients received cesarean section, 53.6% (22\/41) of which received preventive plasma transfusion before surgery and no one received artificial liver support during the treatment.\n                    <\/jats:p>\n                    <jats:p>\n                      In comparison, higher frequency of 16 maternal complications, severe negative outcomes (27.3% vs. 0.9%) and newborn asphyxia (24.6% vs.0.9%) were observed in AFLP population. 3 mothers (mortality rates: 5.5%) died of multiple organ system failure and 6 fetus\/infants (death rates: 9.8%) died of distress. When compared to those without negative outcomes, patients with negative fetal outcomes were younger (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.042), had more singleton rates (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.041), increased mean value of ALT(\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.011) and T-Bilirubin (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u20090.014), decreased prothrombin activity (P\u2009=\u20090.011). Although no statistical significance for the small sample size, there were less refractory postpartum hemorrhage (0% vs.31.3%), hysterectomy (0% vs.12.5%), negative maternal outcomes (16.7% vs.56.3%) in patients underwent intrauterine balloon tamponade when postpartum hemorrhage exceeded 500\u2009ml.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Several symptoms were found to be the main prodromal symptoms of AFLP. Higher frequency of adverse maternal and fetal outcomes was observed in mothers with AFLP than mothers without AFLP. We found five potential risk factors of negative fetal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-020-02980-2","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:02:55Z","timestamp":1589187775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pregnancy outcomes of patients with acute fatty liver of pregnancy: a case control study"],"prefix":"10.1186","volume":"20","author":[{"given":"Lingzhi","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-8826","authenticated-orcid":false,"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2980_CR1","doi-asserted-by":"crossref","unstructured":"Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol. 2013;209:456.e1\u20137.","DOI":"10.1016\/j.ajog.2013.07.006"},{"key":"2980_CR2","doi-asserted-by":"publisher","first-page":"e29077","DOI":"10.1371\/journal.pone.0029077","volume":"6","author":"G Kayem","year":"2011","unstructured":"Kayem G, Kurinczuk J, Lewis G, et al. Risk factors for progression from severe maternal morbidity to death: a national cohort study. PLoS One. 2011;6:e29077.","journal-title":"PLoS One"},{"key":"2980_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJM199906033402204","volume":"340","author":"JA Ibdah","year":"1999","unstructured":"Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999;340:1723\u201331.","journal-title":"N Engl J Med"},{"key":"2980_CR4","doi-asserted-by":"crossref","unstructured":"Wu Z, Huang P, Gong Y, et al. Treating acute fatty liver of pregnancy with artificial liver support therapy: Systematic review. Medicine (Baltimore).2018;97:e12473.","DOI":"10.1097\/MD.0000000000012473"},{"key":"2980_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.11622\/smedj.2018001","volume":"59","author":"Q Gao","year":"2018","unstructured":"Gao Q, Qu X, Chen X, et al. Outcomes and risk factors of patients with acute fatty liver of pregnancy: a multicentre retrospective study. Singap Med J. 2018;59:425\u201330.","journal-title":"Singap Med J"},{"key":"2980_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejogrb.2011.02.015","volume":"157","author":"RR Dekker","year":"2011","unstructured":"Dekker RR, Schutte JM, Stekelenburg J, et al. Maternal mortality and severe maternal morbidity from acute fatty liver of pregnancy in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;157:27\u201331.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2980_CR7","doi-asserted-by":"publisher","first-page":"28826","DOI":"10.1038\/srep28826","volume":"6","author":"HY Wang","year":"2016","unstructured":"Wang HY, Jiang Q, Shi H, et al. Effect of caesarean section on maternal and foetal outcomes in acute fatty liver of pregnancy: a systematic review and meta-analysis. Sci Rep. 2016;6:28826.","journal-title":"Sci Rep"},{"key":"2980_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/jca.20168","volume":"23","author":"JN Martin Jr","year":"2008","unstructured":"Martin JN Jr, Briery CM, Rose CH, et al. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher. 2008;23:138\u201343.","journal-title":"J Clin Apher"},{"key":"2980_CR9","doi-asserted-by":"crossref","unstructured":"Allen AM, Kim WR, Larson JJ, et al. The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol. 2016;14:287\u201394.e1\u20132.","DOI":"10.1016\/j.cgh.2015.08.022"},{"key":"2980_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3109\/14767058.2013.871704","volume":"27","author":"N Cheng","year":"2014","unstructured":"Cheng N, Xiang T, Wu X, et al. Acute fatty liver of pregnancy: a retrospective study of 32 cases in South China. J Matern Fetal Neonatal Med. 2014;27:1693\u20137.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2980_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000351565","volume":"76","author":"G Zhou","year":"2013","unstructured":"Zhou G, Zhang X, Ge S. Retrospective analysis of acute fatty liver of pregnancy: twenty-eight cases and discussion of anesthesia. Gynecol Obstet Investig. 2013;76:83\u20139.","journal-title":"Gynecol Obstet Investig"},{"key":"2980_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/gut.2008.148676","volume":"57","author":"M Knight","year":"2008","unstructured":"Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. UK obstetric surveillance system. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008;57:951\u20136.","journal-title":"Gut"},{"key":"2980_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00404-015-3941-5","volume":"293","author":"J Meng","year":"2016","unstructured":"Meng J, Wang S, Gu Y, et al. Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center. Arch Gynecol Obstet. 2016;293:1185\u201391.","journal-title":"Arch Gynecol Obstet"},{"key":"2980_CR14","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3748\/wjg.v21.i6.1927","volume":"21","author":"HF Xiong","year":"2015","unstructured":"Xiong HF, Liu JY, Guo LM, et al. Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients. World J Gastroenterol. 2015;21:1927\u201331.","journal-title":"World J Gastroenterol"},{"key":"2980_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1744-9987.2006.00358.x","volume":"10","author":"LJ Li","year":"2006","unstructured":"Li LJ, Zhang YM, Liu XL, et al. Artificial liver support system in China: a review over the last 30 years. Ther Apher Dial. 2006;10:160\u20137.","journal-title":"Ther Apher Dial"},{"key":"2980_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ajg.2017.54","volume":"112","author":"J Liu","year":"2017","unstructured":"Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112:838\u201346.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-02980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-02980-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-02980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T19:33:54Z","timestamp":1620675234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-02980-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-02980-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14228\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14228\/v2","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"19 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"282"}}